NPAS2 and prostate carcinoma: Interestingly, a genome-wide association study by the NCI cancer genetic markers of susceptibility (CGEMS) project and a variation of that study by a Chinese group showed that single nucleotide polymorphisms involved in the locus of circadian clock-related NPAS2 are significantly associate with prostate cancer risk [55], [56].